 |
- Major drug study opens up vast new opportunities in combating heart disease The Mercury News
- CANTOS: Canakinumab reduces recurrent CV event rates in MI, inflammation Healio
- New wonder drug hailed as biggest breakthrough in fight against heart attacks and cancer Telegraph.co.ukFull coverage
|
No comments: